The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $51.89

Today's change+0.06 +0.12%
Updated March 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $51.89

Today's change+0.06 +0.12%
Updated March 28 4:00 PM EDT. Delayed by at least 15 minutes.

Baxter International Inc up (U.S.)$0.06

Baxter International Inc closed up Tuesday by (U.S.)$0.06 or 0.12% to (U.S.)$51.89. Over the last five days, shares have gained 0.95% and 17.03% year to date. Shares have outperformed the S&P 500 by 12.40% during the last year.

Key company metrics

  • Open(U.S.) $51.75
  • Previous close(U.S.) $51.83
  • High(U.S.) $51.99
  • Low(U.S.) $51.57
  • Bid / Ask-- / --
  • YTD % change+17.03%
  • Volume2,372,702
  • Average volume (10-day)2,495,802
  • Average volume (1-month)2,845,471
  • Average volume (3-month)3,191,873
  • 52-week range(U.S.) $39.98 to (U.S.) $52.33
  • Beta0.78
  • Trailing P/E5.77×
  • P/E 1 year forward23.94×
  • Forward PEG1.71×
  • Indicated annual dividend(U.S.) $0.52
  • Dividend yield1.00%
  • Trailing EPS(U.S.) $9.00
Updated March 28 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.60%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue2,6452,5582,5852,375
Total other revenue--------
Total revenue2,6452,5582,5852,375
Gross profit1,0651,037855965
Total cost of revenue1,5801,5211,7301,410
Total operating expense2,3592,3201,3695,329
Selling / general / administrative619611663620
Research & development152129150136
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)859-1,1743,163
Other operating expenses, total--------
Operating income2862381,216-2,954
Interest income (expense), net non-operating-20-20-16-33
Gain (loss) on sale of assets--------
Other--------
Income before tax2791281,2183,329
Income after tax2401271,2123,387
Income tax, total3916-58
Net income2431301,2123,380
Total adjustments to net income--------
Net income before extra. items2401271,2123,387
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2401271,2123,387
Inc. avail. to common incl. extra. items2431301,2123,380
Diluted net income2431301,2123,380
Dilution adjustment--------
Diluted weighted average shares548551553552
Diluted EPS excluding extraordinary itemsvalue per share0.440.232.196.14
Dividends per sharevalue per share0.130.130.130.12
Diluted normalized EPSvalue per share0.450.18-0.0411.67